We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAKK icon
3151
Jakks Pacific
JAKK
$280M
$190K ﹤0.01%
+14,954
New +$198K
RCKT icon
3152
Rocket Pharmaceuticals
RCKT
$348M
$190K ﹤0.01%
+13,800
New +$165K
HROW icon
3153
Harrow
HROW
$1.43B
$189K ﹤0.01%
+25,969
New +$175K
HUMA icon
3154
Humacyte
HUMA
$168M
$189K ﹤0.01%
+58,828
New +$327K
MU icon
3155
PUT
Micron Technology
MU
$1.04T
$189K ﹤0.01%
3,400
+3,200
+1,600% +$217K
CTV.WS
3156
CALL
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
$188K ﹤0.01%
113,387
SURF
3157
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$188K ﹤0.01%
+114,183
New +$237K
RLGT icon
3158
Radiant Logistics
RLGT
$416M
$187K ﹤0.01%
25,097
-6,966
-22% -$44.8K
TALK icon
3159
Talkspace
TALK
$873M
$187K ﹤0.01%
+110,044
New +$165K
OTMOW
3160
CALL
DELISTED
Otonomo Technologies Ltd. Warrant
OTMOW
$187K ﹤0.01%
174,862
-16,499
-9% -$2.16K
TCACW
3161
CALL
DELISTED
Tuatara Capital Acquisition Corporation Warrant
TCACW
$187K ﹤0.01%
105,000
AVAL icon
3162
Grupo Aval
AVAL
$5.67B
$186K ﹤0.01%
+52,399
New +$218K
AEVA
3163
Aeva Technologies
AEVA
$1.02B
$184K ﹤0.01%
+11,789
New +$194K
UP icon
3164
Wheels Up
UP
$220M
$181K ﹤0.01%
463
-7,269
-94% -$3.88M
ATCX
3165
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$181K ﹤0.01%
+34,450
New +$326K
ARAY icon
3166
Accuray
ARAY
$28.4M
$180K ﹤0.01%
91,686
-353,947
-79% -$884K
FCEL icon
3167
FuelCell Energy
FCEL
$1.7B
$180K ﹤0.01%
1,604
-1,949
-55% -$246K
CHPT icon
3168
ChargePoint
CHPT
$133M
$178K ﹤0.01%
+653
New +$181K
GAMB
3169
DELISTED
Gambling.com
GAMB
$177K ﹤0.01%
22,518
-31,577
-58% -$264K
AOGO
3170
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$176K ﹤0.01%
17,678
LOTZW
3171
CALL
DELISTED
CarLotz, Inc. Warrant
LOTZW
$176K ﹤0.01%
450,000
CMCL icon
3172
Caledonia Mining Corp
CMCL
$360M
$175K ﹤0.01%
15,752
-977
-6% -$13.3K
OFS icon
3173
OFS Capital
OFS
$43.8M
$174K ﹤0.01%
17,645
-1,076
-6% -$13K
OPAD.WS
3174
CALL
DELISTED
Offerpad Solutions Inc. Warrants, Every 15 warrants will be exercisable for one share of Class A Common Stock at an exercise price of $172.50 per share of Class A Common Stock
OPAD.WS
$173K ﹤0.01%
79,555
+11,247
+16% +$6.95K
PSCE icon
3175
Invesco S&P SmallCap Energy ETF
PSCE
$101M
$171K ﹤0.01%
+3,910
New +$201K

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.